First-degree relatives of colorectal cancer patients are likely to show advanced colorectal neoplasia despite a negative fecal immunochemical test

Digestion

Volumn 86, Issue 4, 2013, Pages 283-287

  Cha, Jae Myung ^a   Lee, Joung Il ^a   Joo, Kwang Ro ^a   Shin, Hyun Phil ^a   Park, Jae Jun ^a   Jeun, Jung Won ^a   Lim, Jun Uk ^a  

^a Kyung Hee University College of Medicine   (South Korea)

Author keywords

Colorectal neoplasia; Fecal immunochemical test; First degree relatives

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; BARIUM ENEMA; COLONOSCOPY; COLORECTAL CANCER; COLORECTAL TUMOR; FALSE NEGATIVE RESULT; FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; FEMALE; FIRST DEGREE RELATIVE; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADENOMA; AGED; CARCINOMA; COLONOSCOPY; COLORECTAL NEOPLASMS; CONFIDENCE INTERVALS; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OCCULT BLOOD; ODDS RATIO; RISK FACTORS;

EID: 84867203013     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000341738     Document Type: Article

References (22)

1. Choi KS, Jun JK, Lee HY, Hahm MI, Oh JH, Park EC: Increasing uptake of colorectal cancer screening in Korea: A populationbased study. BMC Public Health 2010; 10: 265.
2. Shim JI, Kim Y, Han MA, Lee HY, Choi KS, Jun JK, Park EC: Results of colorectal cancer screening of the national cancer screening program in Korea, 2008. Cancer Res Treat 2010; 42: 191-198.
3. Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG: Screening of colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst 1993; 85: 1311-1318.
4. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, Snover DC, Schuman LM: The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343: 1603-1607.
5. Atkin WS, Cuzick J, Northover JM, Whynes DK: Prevention of colorectal cancer by onceonly sigmoidoscopy. Lancet 1993; 341: 736-740.
6. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM: Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-1477.
7. Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O: Randomised study of screening for colorectal cancer with faecaloccult-blood test. Lancet 1996; 348: 1467-1471.
8. Liberman D, Sleisenger MH: It is time to recommend screening for colorectal cancer? Lancet 1996; 348: 1463-1464.
9. Lang CA, Ransohoff DF: Fecal occult blood screening for colorectal cancer. Is mortality reduced by chance selection for screening colonoscopy? JAMA 1994; 271: 1011-1013.
10. Yoo KY: Cancer control activities in the republic of Korea. Jpn J Clin Oncol 2008; 38: 327-333.
11. Toribara NW, Sleisenger MH: Screening for colon cancer. N Engl J Med 1995; 332: 861-867.
12. Kronborg O, Fenger C, Olsen J, Jørgensen OD, Søndergaard O: Randomised study of screening for colorectal cancer with faecaloccult-blood test. Lancet 1996; 348: 1467-1477.
13. Liberman DA: Colon cancer screening. Obstacles to effectiveness. Cancer 1992; 70: 1259-1265.
14. Mandel JS: Colorectal cancer screening. Cancer metastasis Rev 1997; 16: 263-279.
15. Anonymous: Suggested technique for fecal occult blood testing and interpretation in colorectal cancer screening. American College of Physicians. Ann Intern Med 1997; 126: 808-810.
16. Johns LE, Houlston RS: A systematic review and meta-analysis of familial cancer risk. Am J Gastroenterol 2001; 96: 2992-3003.
17. Butterworth AS, Higgins JPT, Pharoah P: Relative and absolute risk of colorectal cancer for individuals with a family history: A meta-analysis. Eur J Cancer 2006; 42: 216-227.
18. van Rossum LG, van Rijn AF, van Oijen MG, Fockens P, Laheij RJ, Verbeek AL, Jansen JB, Dekker E: False negative fecal occult blood tests due to delayed sample return in colorectal cancer screening. Int J Cancer 2009; 125: 746-750.
19. Guillem JG, Forde KA, Treat MR, Neugut AI, O'Toole KM, Diamond BE: Colonoscopic screening for neoplasms in asymptomatic first-degree relatives of colon cancer patients. A controlled, prospective study. Dis Colon Rectum 1992; 35: 523-529.
20. Glanz K, Steffen AD, Taglialatela LA: Effects of colon cancer risk counseling for first-degree relatives. Cancer Epidemiol Biomarkers Prev 2007; 16: 1485-1491.
21. Oort FA, Terhaar Sive Droste JS, Van Der Hulst RW, Van Heukelem HA, Loffeld RJ, Wesdorp IC, Van Wanrooij RL, De Baaij L, Mutsaers ER, van der Reijt S, Coupe VM, Berkhof J, Bouman AA, Meijer GA, Mulder CJ: Colonoscopy-controlled intra-individual comparisons to screen relevant neoplasia: faecal immunochemical test vs. guaiacbased faecal occult blood test. Aliment Pharmacol Ther 2010; 31: 432-439.
22. Mitchell RJ, Campbell H, Farrington SM, Brewster DH, Porteous ME, Dunlop MG: Prevalence of family history of colorectal cancer in the general population. Br J Surg 2005; 92: 1161-1164